Hybridoma Platform
Diverse immune repertoires, high-throughput fusion and systematic clone selection.
- Multi-species capability
- Automated screening
- Stable clone banking
Technology platform
Connected platforms.
Defensible data.
Our scientists combine established biology with disciplined experimental design, creating a transparent line from target strategy to functional evidence.
TP / 04
Recombinant Platform
Sequence-defined discovery and engineering for consistent, scalable molecules.
- Phage display
- Sequence rescue
- Format conversion
Expression Platform
Multiple host systems and purification routes for challenging proteins.
- Microbial to mammalian
- Multi-construct screening
- Analytical SEC
Validation Platform
Orthogonal evidence built around the application and biological context.
- ELISA and kinetics
- WB, IHC and IF
- Flow cytometry and IP
Quality by Design
Stage-gated reviews, controlled records and clear acceptance criteria.
- Method traceability
- Batch documentation
- Retention samples
Scale-up & Transfer
Continuity from discovery quantity to recurring or bulk supply.
- Process optimization
- Lot comparability
- Custom formulation
Validation philosophy
A positive signal is
only the beginning.
We use relevant positive and negative controls, orthogonal methods and application-matched sample types to build a defensible evidence package.
Start with your goal
Ready to move your
program forward?
Share your target and application. Our scientific team will recommend a practical route.
Talk to a scientist ↗